Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions

Core Viewpoint - Texas Attorney General Ken Paxton has filed a lawsuit against Sanofi, alleging that the company engaged in bribery to encourage healthcare providers to prescribe its medications over alternatives [1]. Group 1: Allegations and Legal Actions - The lawsuit claims that Sanofi created programs that provided services to healthcare providers, which are alleged to constitute bribes in violation of the Texas Health Care Program Fraud Prevention Act [1]. - Attorney General Paxton is seeking over a million dollars in monetary relief, including civil penalties, and an injunction to prevent further unlawful acts by Sanofi [1]. - This is not the first legal action against Sanofi; the Attorney General has previously sued the company for failing to disclose the ineffectiveness of its blood clot prevention drug, Plavix, for certain patients [1]. Group 2: Context of Legal Environment - Last year, Texas also sued Eli Lilly for similar allegations of bribing providers to prescribe its most profitable drugs, including GLP-1 medications Mounjaro and Zepbound [1].